U S PHYSICAL THERAPY INC /NV — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that U S PHYSICAL THERAPY INC /NV filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $780.99M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $671.35M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $604.80M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $553.14M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $495.02M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $422.97M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $481.97M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $453.91M | Mar 1, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $780.99M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $671.35M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $604.80M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $553.14M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $495.02M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $422.97M | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | $122.11M | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $117.25M | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $126.37M | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $116.23M | Feb 28, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $109.20M | Mar 14, 2018 |
| FY2017 | Sep 30, 2017 | $103.03M | Mar 14, 2018 |
| FY2017 | Jun 30, 2017 | $104.25M | Mar 14, 2018 |
| FY2017 | Mar 31, 2017 | $97.57M | Mar 14, 2018 |
| FY2017 | Dec 31, 2016 | $90.86M | Mar 14, 2018 |
| FY2017 | Sep 30, 2016 | $88.34M | Mar 14, 2018 |
| FY2017 | Jun 30, 2016 | $90.43M | Mar 14, 2018 |
| FY2017 | Mar 31, 2016 | $86.91M | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | $86.72M | Jun 7, 2017 |
| FY2016 | Sep 30, 2015 | $84.05M | Jun 7, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $149.69M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $123.92M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $121.51M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $112.02M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $117.18M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $94.45M | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | $26.96M | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $27.37M | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $31.43M | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $26.72M | Feb 28, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.58M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $31.42M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $28.24M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $32.16M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $40.83M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $35.19M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $40.04M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $34.87M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $22.26M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $20.55M | Mar 18, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $86.68M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $62.99M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $50.51M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $56.80M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $70.65M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $52.41M | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | $15.29M | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $16.82M | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $19.90M | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $15.43M | Feb 28, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $69.26M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $58.29M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $51.95M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $46.11M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $46.53M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $42.04M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $45.05M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $41.35M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $35.89M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $32.48M | Mar 18, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $75.06M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $74.94M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $81.98M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $58.54M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $76.41M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $100.00M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $62.45M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $73.01M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $56.53M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $51.05M | Mar 18, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.20B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.17B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $997.24M | Mar 3, 2025 |
| FY2024 | Dec 31, 2022 | $858.15M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $749.43M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $594.36M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $630.50M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $443.17M | Mar 1, 2021 |
| FY2018 | Dec 31, 2017 | $418.98M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $351.23M | Mar 14, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $433.81M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $408.42M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $345.00M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $373.59M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $296.98M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $184.39M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $181.39M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $92.35M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $110.34M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $162.54M | Mar 14, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $476.43M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $488.93M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $476.19M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $315.79M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $295.61M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $276.16M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $240.26M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $215.95M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $204.87M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $187.55M | Mar 14, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $692.39M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $667.15M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $509.57M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $494.10M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $434.68M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $345.65M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $317.68M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $293.53M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $271.34M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $226.81M | Mar 18, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $227.22M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $227.27M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $223.77M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $232.95M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $224.40M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $212.02M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $184.35M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $167.40M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $162.41M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $150.34M | Mar 14, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.57M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $41.36M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $152.83M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $31.59M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $28.57M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $32.92M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $23.55M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $23.37M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $21.93M | Mar 18, 2019 |
| FY2018 | Dec 31, 2016 | $20.05M | Mar 18, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $118.42M | Mar 1, 2022 |
| FY2021 | Dec 31, 2020 | $21.50M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $51.09M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $39.84M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $60.77M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $51.82M | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | $49.11M | Jun 7, 2017 |
| FY2015 | Dec 31, 2014 | $35.62M | Mar 4, 2016 |
| FY2014 | Dec 31, 2013 | $41.48M | Mar 12, 2015 |
| FY2013 | Dec 31, 2012 | $18.03M | Mar 11, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | 2 | Mar 1, 2022 |
| FY2015 | Dec 31, 2015 | 0 | Mar 4, 2016 |
| FY2015 | Sep 30, 2015 | 0 | Mar 4, 2016 |
| FY2015 | Jun 30, 2015 | 0 | Mar 4, 2016 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | 2 | Mar 1, 2022 |
| FY2015 | Dec 31, 2015 | 0 | Mar 4, 2016 |
| FY2015 | Sep 30, 2015 | 0 | Mar 4, 2016 |
| FY2015 | Jun 30, 2015 | 0 | Mar 4, 2016 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | 12.68M | Mar 18, 2019 |
| FY2018 | Dec 31, 2017 | 12.59M | Mar 18, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.36M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $26.54M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $24.13M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $21.32M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $18.77M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $4.11M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $14.56M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $11.66M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $10.07M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $8.51M | Mar 18, 2019 |